We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more
Prioritizing autoimmune programs aims to focus upon near-term and intermediate value creation potential, while retaining oncology programs as promising clinical data continues to mature - Company...
Overall response rate (ORR) of 46% and 12-month overall survival (OS) of 96% in first line (1L) recurrent/metastatic (R/M) HPV+ head and neck squamous cell carcinoma (HNSCC) treated with CUE-101...
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.125 | -15.3751537515 | 0.813 | 0.813 | 0.67 | 265216 | 0.73962384 | CS |
| 4 | -0.722 | -51.2056737589 | 1.41 | 1.4385 | 0.67 | 598083 | 1.03704414 | CS |
| 12 | -1.212 | -63.7894736842 | 1.9 | 2.26 | 0.67 | 380018 | 1.32166488 | CS |
| 26 | -2.022 | -74.6125461255 | 2.71 | 2.82 | 0.67 | 323135 | 1.63863588 | CS |
| 52 | -3.152 | -82.0833333333 | 3.84 | 3.95 | 0.67 | 328721 | 2.18078991 | CS |
| 156 | -9.762 | -93.4162679426 | 10.45 | 18.42 | 0.67 | 313284 | 4.8002727 | CS |
| 260 | -6.332 | -90.1994301994 | 7.02 | 35.5 | 0.67 | 298529 | 8.99938662 | CS |
Monksdream
4 weeks ago
Hawkeye_tt
1 year ago
conix
2 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
